<p><strong>Sjogren's Disease</strong></p>
<p>Sjogren's syndrome is a chronic autoimmune rheumatic disease with a specific predisposition for causing inflammation of the exocrine glands, predominantly the salivary and lacrimal glands, including the nose, upper respiratory tract, oropharynx, and the vagina in women. The immune system inappropriately attacks various cells, which leads to the activation of the various pathway, which results in inflammation. The main consequence of this inflammation is the development of sicca symptoms due to damage to salivary and tear glands, such as dryness of the mucosal surfaces, principally in the mouth and eyes.</p>
<p>&nbsp;</p>
<h2><strong><a href="https://www.delveinsight.com/report-store/sjogrens-syndrome-epidemiology-forecast"><span style="text-decoration: underline;">Sjogren's Disease Epidemiology Segmentation</span></a> in the 7MM</strong></h2>
<ul>
<li>Total diagnosed cases of Sjogren's Disease</li>
<li>Total number of gender specific of Sjogren's Disease</li>
<li>Total number of type specific of Sjogren's Disease</li>
<li>Total number of severity specific of Sjogren's Disease</li>
</ul>
<p>&nbsp;</p>
<h3><strong>Sjogren's Disease Epidemiological Insights Observed in the 7MM (2021)</strong></h3>
<ul>
<li>The total cases of Sjogren's Disease in the 7MM was approximately 3 Million in the year 2021.</li>
<li>In the United States, Sjogren's Disease prevalence was approximately 174,000 cases in males and 1.5 Million cases in females.&nbsp;</li>
</ul>
<h2><strong><a href="https://www.delveinsight.com/report-store/sjogrens-syndrome-market-size"><span style="text-decoration: underline;">Sjogren's Disease Market Insight</span></a>&nbsp;</strong></h2>
<p>The Sjogren's Disease market size in the 7MM is anticipated to increase with a significant <strong>CAGR </strong>during the study period 2019-32.</p>
<p>&nbsp;</p>
<h3><strong>Sjogren's Disease Emerging drugs</strong></h3>
<p>The emerging drugs in the Sjogren's Disease market are</p>
<ul>
<li>RSLV-132</li>
<li>VAY736</li>
<li>CFZ533</li>
<li>Belimumab</li>
<li>RO5459072</li>
<li>LOU-064</li>
<li>Abatacept</li>
<li>Lacripep</li>
<li>Parsaclisib</li>
<li>Filgotinib</li>
<li>GS-9876</li>
<li>VIB7734</li>
</ul>
<h3><strong>Sjogren's Disease key players</strong></h3>
<p>The key players working in the&nbsp; Sjogren's Disease market are</p>
<ul>
<li>Resolve Therapeutics</li>
<li>Novartis</li>
<li>MorphoSys</li>
<li>GlaxoSmithKline</li>
<li>Roche</li>
<li>Bristol Myers Squibb</li>
<li>TearSolutions</li>
<li>Incyte Corporation</li>
<li>Galapagos NV&nbsp;</li>
<li>Gilead Sciences</li>
<li>VIELABIO</li>
</ul>

Sjogren’s Syndrome Market

Sjogren’s Syndrome Market Infograhics

Sjogren’s Syndrome Symptoms, Treatment, epidemiology, companies, drugs infographic is a short guide to understand the problem and market landscape.